Concepedia

Lisen Arnheim‐Dahlström

LA

Statistics

Publications

49

Citations

3.1K

H-Index

33

Active since

2009

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Lund University

Danish Cancer Society

Merck & Co., Inc., Rahway, NJ, USA (United States)

Lisen Arnheim‐Dahlström is an author at Karolinska Institutet specializing in medicine, human papillomavirus vaccines, and public health.

ORCID

Top concepts

Publications per year

2009–2022

49

Publications

49

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

Lisen Arnheim‐Dahlström, Björn Pasternak, Henrik Svanström et al. · BMJ · 2013 · 269 citations · Full text

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

Leonoor Wijnans, Coralie Lecomte, Corinne S de Vries et al. · Vaccine · 2012 · 233 citations · Full text

, , +4

Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System

Nikolai Madrid Scheller, Henrik Svanström, Björn Pasternak et al. · JAMA · 2015 · 173 citations

Cervical cancer screening in Europe: Quality assurance and organisation of programmes

K. Miriam Elfström, Lisen Arnheim‐Dahlström, Lawrence von Karsa et al. · European Journal of Cancer · 2015 · 167 citations

, , +10

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study

Amy Levál, Eva Herweijer, Alexander Ploner et al. · JNCI Journal of the National Cancer Institute · 2013 · 144 citations · Full text

1–5 of 49